SCHEMBL3468449

SCHEMBL3468449

O=C(O)CCCCCCCCCCCCCCCCCCCCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 4/20 0.69
HDAC3 O15379 3/20 0.69
HDAC4 P56524 3/20 0.69
HDAC1 Q13547 3/20 0.69
HDAC7 Q8WUI4 3/20 0.69
HDAC2 Q92769 3/20 0.69
HDAC10 Q969S8 3/20 0.69
HDAC11 Q96DB2 3/20 0.69
HDAC6 Q9UBN7 3/20 0.69
HDAC9 Q9UKV0 3/20 0.69
HDAC5 Q9UQL6 3/20 0.69
HPGD P15428 5/20 0.68
SMN1; SMN2 Q16637 2/20 0.68
KMT2A Q03164 3/20 0.65
MEN1 O00255 2/20 0.65
L3MBTL1 Q9Y468 2/20 0.63
TDP1 Q9NUW8 1/20 0.63
ALDH1A1 P00352 3/20 0.62
MAPK1 P28482 1/20 0.62
GAA P10253 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31035987 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL9947534 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL9130049 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL9350109 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL4202491 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL3468927 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL9899475 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL133529 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL607631 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7
SCHEMBL10670786 1.00 HDAC8 (0.69) HDAC8HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2261662-B1 Novel synthetic blocking reagents FORSCHUNGSZENTRUM BORSTEL LEIBNIZ ZENTRUM FUER MEDIZIN UND BIOWISSENSCHAFTEN (DE) 2014-01-22 EP disclosed
US-8501199-B2 Synthetic blocking reagents FORSCHUNGSZENTRUM BORSTEL (DE) 2013-08-06 US disclosed
US-20100317048-A1 NOVEL SYNTHETIC BLOCKING REAGENTS FORSCHUNGSZENTRUM BORSTEL (DE) 2010-12-16 US disclosed
EP-2261662-A1 Novel synthetic blocking reagents Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften (DE) 2010-12-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317048-A1 NOVEL SYNTHETIC BLOCKING REAGENTS SPR, SSB, LY96 HDAC8 4278/4885HDAC3 3976/4885HDAC4 4421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.